Filterlex Medical
Manufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Yoqne`am `Illit, Northern District, Isra...Website
www.filterlex.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Filterlex Medical
Filterlex Medical specializes in developing next-generation embolic protection devices, specifically the CAPTIS Full-Body Embolic Protection Device, aimed at reducing the risk of stroke and other complications during catheter-based structural heart procedures like TAVI. The CAPTIS device features a unique triple action design that deflects, captures, and removes embolic particles while ensuring seamless integration into the procedure without additional access. The company targets healthcare professionals and institutions involved in cardiovascular procedures, focusing on enhancing patient safety and procedural efficiency. Filterlex has received recognition and funding for its innovative approach, including a Best Innovation Award at EuroPCR and support from the European Innovation Council.Explore more
Filterlex Medical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Filterlex Medical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Filterlex Medical, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Filterlex Medical had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Filterlex Medical recently announced quarterly report
Check if Filterlex Medical has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Filterlex Medical
Check out if Filterlex Medical is spiking on competitors!
Product Launch: Get notified when Filterlex Medical launches new products
Funding: Get notified immidiatlly once Filterlex Medical has new funding data
Recommended Actions
Reach out to Masked Content who joined Filterlex Medical as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Filterlex Medical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Filterlex Medical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Filterlex Medical.
Filterlex Medical financials insights
Gather financial insights about Filterlex Medical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$3M
2021
Series A
$6M
Filterlex Medical Tech Stack
A closer look at the technologies used by Filterlex Medical
Filterlex Medical News & Media
Filterlex Medical Announces Positive Results from A First-In-Human Study for the CAPTIS® Full-Body Embolic Protection Device
Cardiovascular data presented at EuroPCR 2022 demonstrates successful device performance during a TAVR procedure with no complications. CAESAREA, Israel, May 31, 2022 /PRNewswire/ -- Filterlex Medical Ltd., a cardiovascular medical device startup, announced today results from a...Filterlex Medical Successfully Completes First-In-Human Study for CAPTIS® Full-Body Embolic Protection Device
Cardiovascular study results to be presented by Prof. Ran Kornowski, Director of the Cardiology Center, Rabin Medical Center at the EuroPCR 2022 conference in May CAESAREA, Israel, May 10, 2022 /PRNewswire/ -- Filterlex Medical Ltd., a cardiovascular medical device startup, announced...Cardiovascular Startup, Filterlex Medical, Selected to Receive €7M from the European Innovation Council
CAESAREA, Israel, Dec. 21, 2021 /PRNewswire/ -- Filterlex Medical, a cardiovascular medical device startup, announced today that it has been selected to receive €7 Million equity investment from the European Innovation Council Accelerator (EIC). The EIC equity investment will be a part of...Filterlex Medical Closes a $6Million Series A1 Investment to Accelerate the CAPTIS® Cardiovascular Clinical Program
CAESAREA, Israel, Nov. 18, 2021 /PRNewswire/ -- Filterlex Medical, a cardiovascular medical device startup, announced today that it has recently completed a US $6 Million series A1 investment round from leading private healthcare investors. The financing will accelerate implementation of...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Filterlex Medical
Sign Up For FreeTo access detailed company insights
Filterlex Medical specializes in developing next-generation embolic protection devices, specifically the CAPTIS Full-Body Embolic Protection Device, aimed at reducing the risk of stroke and other complications during catheter-based structural heart procedures like TAVI. The CAPTIS device features a unique triple action design that deflects, capture... Read More
